Etoposide

nuclear factor kappa B subunit 1 ; Homo sapiens







38 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29643533 [Topoisomerase inhibitor upregulates MICA/B expression in breast cancer cells through ATM/ATR and NF-κB pathway]. 2018 Apr 18 4
2 30121250 JNK-AKT-NF-κB controls P-glycoprotein expression to attenuate the cytotoxicity of deoxynivalenol in mammalian cells. 2018 Oct 1
3 28400607 PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB. 2017 Apr 11 5
4 25662950 Insulin-like growth factor binding protein-3 enhances etoposide-induced cell growth inhibition by suppressing the NF-κB activity in gastric cancer cells. 2015 May 3
5 23435429 NF-κB is a critical mediator of BRCA1-induced chemoresistance. 2014 Feb 6 6
6 24220725 Extract of Bryophyllum laetivirens reverses etoposide resistance in human lung A549 cancer cells by downregulation of NF-κB. 2014 Jan 4
7 22705319 BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response. 2012 Dec 21 1
8 20102612 Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms. 2010 Jan 26 4
9 21364648 p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma. 2010 May 13 2
10 19065652 Sensitization of neuroblastoma cells for TRAIL-induced apoptosis by NF-kappaB inhibition. 2009 Mar 15 1
11 18421578 Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment. 2008 Jun 5
12 18583959 Induction of a pro-apoptotic ATM-NF-kappaB pathway and its repression by ATR in response to replication stress. 2008 Jul 23 1
13 16424027 Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation. 2006 Jan 15 1
14 17132229 Signaling from p53 to NF-kappaB determines the chemotherapy responsiveness of neuroblastoma. 2006 Nov 2
15 17215959 Signaling from p53 to NF-kappa B determines the chemotherapy responsiveness of neuroblastoma. 2006 Nov 2
16 15694838 p21 (Waf1/Cip1) and FasL gene activation via Sp1 and NFkappaB is required for leukemia cell survival but not for cell death induced by diverse stimuli. 2005 Apr 2
17 15972853 Enhanced G2-M arrest by nuclear factor-{kappa}B-dependent p21waf1/cip1 induction. 2005 Jun 1
18 16123594 The two faces of NFkappaB in cell survival responses. 2005 Oct 1
19 14630082 Dual role of NF-kappaB in apoptosis of THP-1 cells during treatment with etoposide and lipopolysaccharide. 2004 Jan 2
20 15050749 CD30-induced up-regulation of the inhibitor of apoptosis genes cIAP1 and cIAP2 in anaplastic large cell lymphoma cells. 2004 Apr 1
21 15368357 PI-3-kinase/NF-kappaB mediated response of Jurkat T leukemic cells to two different chemotherapeutic drugs, etoposide and TRAIL. 2004 Oct 1 1
22 12637521 Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. 2003 May 16 1
23 11803469 TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent, genotoxin-induced apoptosis of cancer cells. 2002 Jan 10 1
24 11830551 Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. 2002 Feb 1 1
25 11942326 N-acetyl-L-cysteine enhances chemotherapeutic effect on prostate cancer cells. 2002 Mar 1
26 12138192 The zinc finger domain of NEMO is selectively required for NF-kappa B activation by UV radiation and topoisomerase inhibitors. 2002 Aug 1
27 12207174 Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines. 2002 Oct 1
28 11314019 Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. 2001 Feb 15 3
29 11322928 Alteration of nuclear factor-kappaB (NF-kappaB) expression in bone marrow stromal cells treated with etoposide. 2001 May 15 3
30 11593412 Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance. 2001 Sep 20 2
31 10930537 Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation. 2000 Sep 15 3
32 10321832 Extracellular matrix inhibits apoptosis and enhances endothelial cell differentiation by a NfkappaB-dependent mechanism. 1999 Jun 1 2
33 9448741 Role of protein tyrosine phosphorylation in etoposide-induced apoptosis and NF-kappa B activation. 1998 Jan 15 1
34 9454737 cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells. 1998 Mar 1
35 9660938 DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. 1998 Mar 1
36 14517454 Tubular morphogenesis by genotoxic therapeutic agents that induce NF-kappaB activation in human vascular endothelial cells. 1998 5
37 8932379 Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells. 1996 Nov 1 2
38 7986199 Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. 1994 Nov 16 1